Yourgene Health PLC
LSE:YGEN
Yourgene Health PLC
LSE:YGEN
Price:
0.515
GBX
Market Closed
Market Cap:
£16.4m
Balance Sheet
Balance Sheet Decomposition
Yourgene Health PLC
Yourgene Health PLC
Balance Sheet Decomposition is not available for
Yourgene Health PLC
Yourgene Health PLC
Balance Sheet
Yourgene Health PLC
Yourgene Health PLC
Currency: GBP
| Mar-2012 | Mar-2013 | Mar-2014 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1
|
1
|
1
|
1
|
1
|
0
|
1
|
3
|
7
|
8
|
|
| Cash |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
1
|
1
|
1
|
0
|
1
|
0
|
1
|
3
|
7
|
8
|
|
| Short-Term Investments |
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
3
|
4
|
3
|
3
|
6
|
5
|
6
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
3
|
1
|
2
|
5
|
4
|
4
|
|
| Other Receivables |
0
|
0
|
0
|
2
|
1
|
2
|
1
|
1
|
1
|
2
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
6
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
|
| Total Current Assets |
1
|
1
|
0
|
9
|
6
|
4
|
5
|
10
|
16
|
22
|
|
| PP&E Net |
0
|
0
|
0
|
2
|
3
|
2
|
2
|
5
|
8
|
18
|
|
| PP&E Gross |
0
|
0
|
0
|
2
|
0
|
2
|
2
|
5
|
8
|
18
|
|
| Accumulated Depreciation |
0
|
1
|
1
|
1
|
0
|
3
|
4
|
5
|
6
|
9
|
|
| Intangible Assets |
3
|
1
|
0
|
0
|
2
|
1
|
1
|
10
|
15
|
13
|
|
| Goodwill |
0
|
0
|
0
|
0
|
7
|
7
|
7
|
11
|
9
|
9
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
|
| Other Assets |
0
|
0
|
0
|
0
|
7
|
7
|
7
|
11
|
9
|
9
|
|
| Total Assets |
4
N/A
|
3
-27%
|
0
N/A
|
10
N/A
|
18
+67%
|
15
-17%
|
16
+7%
|
38
+142%
|
49
+30%
|
64
+30%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
3
|
2
|
2
|
3
|
3
|
4
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
2
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
|
| Other Current Liabilities |
0
|
0
|
0
|
5
|
3
|
1
|
1
|
2
|
3
|
1
|
|
| Total Current Liabilities |
0
|
0
|
0
|
7
|
7
|
5
|
4
|
6
|
9
|
12
|
|
| Long-Term Debt |
0
|
0
|
0
|
1
|
4
|
12
|
0
|
3
|
4
|
16
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Liabilities |
0
N/A
|
0
-57%
|
0
N/A
|
9
N/A
|
12
+30%
|
17
+47%
|
5
-71%
|
11
+132%
|
16
+42%
|
31
+93%
|
|
| Equity | |||||||||||
| Common Stock |
9
|
10
|
0
|
32
|
32
|
32
|
32
|
33
|
33
|
33
|
|
| Retained Earnings |
28
|
32
|
0
|
58
|
55
|
63
|
60
|
57
|
67
|
68
|
|
| Additional Paid In Capital |
21
|
23
|
0
|
27
|
28
|
28
|
38
|
51
|
67
|
68
|
|
| Other Equity |
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
3
N/A
|
3
-22%
|
0
N/A
|
1
N/A
|
6
+293%
|
3
N/A
|
11
N/A
|
26
+146%
|
33
+25%
|
33
-1%
|
|
| Total Liabilities & Equity |
4
N/A
|
3
-27%
|
0
N/A
|
10
N/A
|
18
+67%
|
15
-17%
|
16
+7%
|
38
+142%
|
49
+30%
|
64
+30%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
12
|
15
|
0
|
228
|
321
|
321
|
459
|
616
|
723
|
727
|
|
Switch to:
Switch to:
See Also
Discover More
